NEW YORK – The UK Medicine and Healthcare Products Regulatory Agency (MHRA) this week issued a new guidance on how the country will regulate in vitro diagnostics after Jan. 1, 2021, when the transition period following the UK's exit from the European Union ends.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.